The TransEnterix European Patient Registry
- Conditions
- Surgery
- Registration Number
- NCT03385109
- Lead Sponsor
- Asensus Surgical
- Brief Summary
An open label observational registry trial in which participating centers enroll subjects who had or will have a laparoscopically assisted surgery using the Senhance Surgical System.
- Detailed Description
This is a prospective multi-center registry in which sites may also choose to retrospectively enroll subjects meeting the inclusion criteria, but whom have already been treated using the Senhance system. The data collection includes baseline patient characteristics, surgical details, and adverse events. Patient follow-up time point is open to the clinical practice of each center and only adverse events are tracked post discharge.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 500
- patients 18-80 years old
- Signed the informed consent
- life expectancy 12 months or more
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adverse Event Surgery to 30 days post op Any untoward sign symptom or disease
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
St. Marien-Krankenhaus
🇩🇪Siegen, Germany
St. Marien-Krankenhaus🇩🇪Siegen, GermanyFrank Willeke, MDContact+44 0271 231 1509f.willeke@marienkrankenhaus.comDietmar Stephan, MDPrincipal Investigator